Scott L. Friedman, MD
Scott L. Friedman, MD, Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai, in November became the first individual to receive three honors at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting. Dr. Friedman received the Distinguished Achievement Award of AASLD and the Distinguished Scientific Achievement Award of the American Liver Foundation. He also delivered the Hans Popper Basic Science State-of-the-Art Lecture in Research. “It was a tremendous honor and an unforgettable day,” he says. Under Dr. Friedman’s leadership, Mount Sinai’s Division of Liver Diseases has grown into the largest liver medicine program in the United States, hosting the nation’s largest liver clinical fellowship training program and supporting groundbreaking basic and clinical studies in hepatic fibrosis and chronic liver disease. The Division, in partnership with The Tisch Cancer Institute and other key departments, also leads the only National Cancer Institute-designated liver cancer program in the country.